CINC
Cincor Pharma, Inc.
No insider bought or sold Cincor Pharma, Inc. in the last 12 months
CINC over the last year
Prices for CINC aren't in yet.
CINC after insider buys
3 months after each buy, from the first price a copier could get.
3 buys since 2022 with 3 months of prices.
Every filing
16 insider filings since 2022, newest first
James Healy · Director and 10% owner
5Am Partners Vi, LLC · 10% owner
Sofinnova Partners Sas · 10% owner
James Healy · Director and 10% owner
General Atlantic Genpar (Bermuda), L.P. · 10% owner
Sofinnova Venture Partners X, L.P. · 10% owner
General Atlantic, L.P. · 10% owner
General Atlantic Genpar (Bermuda), L.P. · 10% owner
General Atlantic, L.P. · 10% owner
James Healy · Director and 10% owner
5Am Partners Vi, LLC · 10% owner
Sofinnova Venture Partners X, L.P. · 10% owner
Sofinnova Partners Sas · 10% owner
Mason Freeman · EVP Clinical Development
Garidel Marc De · CEO
Catherine Pearce · COO
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.